Clinical Oncologist at Oxford Cancer Centre and Associate Professor at the University of Oxford. @ChelseaFC fan. Opinions are mine.
Oxford, UK
- Tweets 537
- Following 419
- Followers 257
- Likes 1,871
David Cutter retweeted
New paper alert 👀 thank you to @Haematologica for publishing our analysis of ~30,000 UK classic Hodgkin lymphoma patients, with a focus on the ever-interesting older population. NB: anthracycline is key! haematologica.org/article/vi… @DavidJCutter @graham74GC
4
7
31
8,372
David Cutter retweeted
Our @glow_nlphl lead Dr. @JamieFlerlage spoke about the GLOW multicenter study of radiation therapy outcomes for Stage IA NLPHL which she presented at #18ICML for @VJHemOnc. #lymsm #NLPHLsm
vjhemonc.com/video/amtyhj8pq…
4
12
778
David Cutter retweeted
If you’re at #ICML2025 come by my poster 1230-1300. We examine survival by anthracycline use in older cHL patients. TLDR: use anthracycline if at all possible! @DavidJCutter @graham74GC
2
8
46
2,652
David Cutter retweeted
View the latest NNHLA Quarterly Data Dashboard here: bit.ly/4j21CpP
@HQIP @JillStoddart @lymphomahub @LLSusa @LymphomaAction @lymphoma @DavidJCutter @NHSEngland @AnthonyNolan @bloodcancer_uk @BloodCancer_Res
#data #NHL #Cancer
4
5
261
David Cutter retweeted
📢Our latest newsletter provides updates on: State of the Nation reporting, our Quarterly Clinical Performance Indicator report, the recent @NATCAN_news webinar & details of the latest report from @bloodcancer_uk 📰 bit.ly/4i2c1Br @HQIP @LymphomaAction @Ed_Pinches #NHL
1
7
991
David Cutter retweeted
Out this week, this new publication explores how the distribution of trial site locations, may lead to disparities in patient representation in clinical trials. bit.ly/416VENC @DavidJCutter @LymphomaAction @bloodcancer_uk @NATCAN_news @WileyGlobal @NHSEngland @HQIP
2
4
154
David Cutter retweeted
Having learned every @BritSocHaem guideline off by heart for my FRCPath, it was very exciting to have been afforded the opportunity to lead an amazing group of co-authors for our GPP regarding bleomycin use in Hodgkin Lymphoma- published today!
onlinelibrary.wiley.com/doi/…
2
15
51
7,354
David Cutter retweeted
Moving beyond mean heart dose: The importance of cardiac substructures in radiation therapy toxicity.
onlinelibrary.wiley.com/doi/…
20
51
3,643
David Cutter retweeted
Abscopal effect does exist in #Hodgkin lymphoma when RT 20Gy is given to PD-1 treated patiens. New distant responses seen outside RT fields. Pembro-RT an option in R/R HL with limited disease #ISHL13 #lymsm dr Christian Bauses. Also safe with RT with low doses! AERN trial !
3
16
1,035
David Cutter retweeted
Thanks to Rajana Advani for including our data in the Best of #ISHL13 session. What a phenomenal three days- so much exciting science and practice-changing trial data, and so many new friends made with exciting future collaboration potential.
1
4
13
1,779
David Cutter retweeted
Great presentation by @ABarrettHaem on the NHSE dataset of older pts with Hodgkin lymphoma. ABVD assoc with best outcomes but of course used in fitter pts. Profound impact of age, PS, comorbidities in this age group. #ISHL13 #lymsm
6
18
3,370
David Cutter retweeted
Fascinating - the hospital at which a patient with Hodgkin lymphoma is treated in England has more effect on the variation in radiotherapy usage than sex of the patient. Suggests standardisation of approach is not yet achieved! #ISHL13 #lymsm. @DavidJCutter @DavidAdrwJones
1
2
8
1,761
David Cutter retweeted
Excited to be here at #ISHL13 , come along Sunday at 3pm for my talk about our registry analysis @DavidJCutter and swing by our posters regarding translational analysis of the ANIMATE study and our data collection project HoOP @graham74GC #hodgkinlymphoma
1
4
18
2,939
David Cutter retweeted
We promised you something exciting was coming... Our first quarterly report which includes clinical performance indicators & is presented on a new,highly interactive dashboard! 💥 bit.ly/3Ni3PyL
@HQIP @LymphomaAction @bloodcancer_uk @DavidJCutter @KateWalkerLon #NHL
2
2
209
David Cutter retweeted
Watch this space! 👀Our latest NNHLA quarterly report is out tomorrow. We won't spoil the surprise, but we've been working on some changes and this time something is different!..... 🤫🏥📊🔎 @HQIP @JillStoddart @bloodcancer_uk @LymphomaAction @BritSocHaem @DavidJCutter
1
3
328
David Cutter retweeted
📢💥It's here! We are delighted to share our first State of the Nation report; along with a number of supplementary materials. Our thanks to everyone involved in its development. bit.ly/3XmI5q7
@HQIP @LymphomaAction @bloodcancer_uk @DavidJCutter @KateWalkerLon
3
5
857
David Cutter retweeted
Exciting news! ⭐️The first NNHLA State of the Nation report is out tomorrow! Check this space or the @NATCAN_news webpages for details bit.ly/3TkRE7J #BCAM
@LymphomaAction @bloodcancer_uk @LLSusa @AnthonyNolan @HQIP @NHSEngland @DavidJCutter @macmillancancer @MJAhearne
3
6
456
David Cutter retweeted
The NNHLA Quality Improvement Plan has landed! The plan sets out:
⭐️5 QI goals
⭐️11 performance indicators
Read the full report here bit.ly/3AKNvmX
@LymphomaAction @LLSusa @bloodcancer_uk @BritSocHaem @AnthonyNolan @HQIP @JillStoddart @DavidJCutter @KateWalkerLon
📢 The new Quality Improvement (QI) Plans are live!
Read them here bit.ly/4gag9OL💡
The audits have developed key QI goals and performance indicators to monitor progress, aiming for these to be measurable, actionable, and improvable.
@RCSnews @HQIP @NHSEngland @LSHTM
1
5
248